Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
暂无分享,去创建一个
J. Schellens | J. Beijnen | J. Schellens | A. Schinkel | J. Jonker | J. Smit | M. Maliepaard | A H Schinkel | J H Beijnen | R. F. Brinkhuis | M Maliepaard | J W Jonker | J W Smit | R F Brinkhuis | J H Schellens
[1] G. Nolan,et al. Expression of Rho GTPases using retroviral vectors. , 2000, Methods in enzymology.
[2] T. Litman,et al. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. , 1999, Cancer letters.
[3] O. van Tellingen,et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.
[4] J. Schellens,et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. , 1999, Cancer research.
[5] J. Wijnholds,et al. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. , 1999, Cancer research.
[6] H. M. Bender,et al. Role of blood‐brain barrier P‐glycoprotein in limiting brain accumulation and sedative side‐effects of asimadoline, a peripherally acting analgaesic drug , 1999, British journal of pharmacology.
[7] J. Schellens,et al. Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[8] M Dietel,et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. , 1999, Journal of the National Cancer Institute.
[9] T. Litman,et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.
[10] L. Doyle,et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Vincenzo,et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.
[12] J. Schellens,et al. Co-administration of cyclosporin enables oral therapy with paclitaxel , 1998, The Lancet.
[13] A. Schinkel,et al. The physiological function of drug-transporting P-glycoproteins. , 1997, Seminars in cancer biology.
[14] J. Beijnen,et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. C. Dubbelman,et al. Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide. , 1997, British Journal of Cancer.
[16] Piet Borst,et al. Substantial excretion of digoxin via the intestinal mucosa and prevention of long‐term digoxin accumulation in the brain by the mdrla P‐glycoprotein , 1996, British journal of pharmacology.
[17] G. Nolan,et al. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. , 1996, Human gene therapy.
[18] J. Beijnen,et al. Clinical Pharmacokinetics of Topotecan , 1996, Clinical pharmacokinetics.
[19] J. Verweij,et al. Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor. , 1996, British Journal of Cancer.
[20] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[21] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[22] C. Vergely,et al. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. , 1993, Cancer research.
[23] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[24] C. Yu,et al. Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. , 1991, Cancer research.
[25] B. Achinstein,et al. Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.
[26] D. Housman,et al. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.
[27] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.